We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Avillion Expands Leadership Team
News

Avillion Expands Leadership Team

Avillion Expands Leadership Team
News

Avillion Expands Leadership Team

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Avillion Expands Leadership Team"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Avillion LLP has announced the expansion of its leadership team with the appointment of Ramani Varanasi, MSc, MBA, as Chief Business Officer.

Ramani is an accomplished business executive, bringing over 18 years of biotechnology and pharmaceutical industry experience to Avillion.

She has a distinguished track record in structuring, negotiating and executing successful strategic alliances, licensing agreements and M&A transactions as well as providing business development, management and strategic leadership to organizations.

Over her career, Ramani has held research and senior level positions in business & corporate development including at Merck, Millennium/Takeda, Momenta Pharmaceuticals, Archemix and RXi Pharmaceuticals.

Lewis Cameron, CEO of Avillion, commented: "We are excited to have Ramani on the Avillion team, where our key focus is the execution of co-development and financing deals with pharma and biotech companies. Her experience and leadership in business and corporate development will support Avillion in its goal of establishing partnerships on late-stage clinical assets."

Ramani holds a BSc and an MSc from McGill University in Microbiology & Immunology and Biochemistry, respectfully, and an MBA in General Strategy from Northeastern University.

Advertisement